FdaApplication
NDA 214200
Identifiers
- fda_app_no: NDA214200
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMACOSMOS AS |
| application_type | NDA |
| approval_date | 2021-02-12 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| COSELA | TRILACICLIB DIHYDROCHLORIDE | EQ 300MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product